FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37056211000001100: Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
173641000001119 Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
173651000001116 Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely atenolol 50 milligram and chlortalidone 12.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Atenolol true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Chlortalidone true Inferred relationship Existential restriction modifier
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has AMP True Co-tenidone 50mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start